BioMarin Pharma (BMRN) Sees FY12 Sales of About $500M, vs. $496M Consensus
Tweet Send to a Friend
Shares of BioMarin Pharmaceuticals, Inc. (Nasdaq: BMRN) are ticking ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


